Subscribe To
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Ultragenyx and mereo biopharma announce interim phase 2 data from phase 2/3 orbit study demonstrating setrusumab (ux143) significantly reduced fracture rates in patients with osteogenesis imperfecta (
Phase 2 data presented at ASBMR 2023 show treatment with setrusumab resulted in 67% reduction in annualized fracture rate associated with continuous a...
October 14, 2023, 8:30 pm
Weekly crypto market overview: xrp traders win big, binance begins a countdown, btc miners move $60m
Key Insights: Bitcoin price made a decent recovery following the US CPI data released on Thursday, but it appears the BTC ...
October 14, 2023, 12:55 pm
Bitcoin price analysis: here’s how btc could perform this weekend
Technical indicators provide insights into how the Bitcoin miners’ recent trading activity could impa...
October 13, 2023, 10:39 pm
mineralys therapeutics announces upcoming poster presentations at two scientific conferences in november 2023
Late-breaking poster presentation at ASN’s Kidney Week 2023 – – –Poster presentation at AHA’s Scientific Sessions 2023 RADNOR, Pa., Oct. 13,...
October 13, 2023, 8:10 pm
Why hecla mining stock blasted higher today
The miner, which concentrates largely on precious metals, released an operational update. It detailed m...
October 13, 2023, 6:02 pm
Gold price recovery sends mining stocks surging
Great news for gold stocks today, as miners got a second wind thanks to a huge uptick in gold prices. W...
October 13, 2023, 5:59 pm
Buy gdx before it's too late
Gold miners have faced headwinds due to shifting interest rate expectations, impacting their performanc...
October 13, 2023, 2:52 pm
Gold forecast – prices bottomed and the march towards $2100 has begun
The final washout in metals and miners is over, and we may be in the beginning stages of a substantial ...
October 13, 2023, 2:12 pm
Newcrest mining investors strongly approve takeover by newmont
Newcrest Mining Limited (ASX:NCM), Australia's biggest gold miner, announced on Friday that its shareho...
October 13, 2023, 1:39 pm
Assessing bitcoin miners ahead of 2024 halving
Bitcoin is heading toward another halving in April 2024, an event that will bring with it significance for min...
October 13, 2023, 10:45 am
Sociedad quimica y minera de chile well positioned lithium stock
For a minute, people rushed into lithium at a pace that made the chemical seem more critical than water. What is the reason?...
October 13, 2023, 9:30 am
Bitcoin miners running up texans’ electricity bills, industry fighting new regulations
Bitcoin miners promised Texans that data centers consuming enormous amounts of energy to generate an im...
October 13, 2023, 9:14 am
Kimbell royalty partners looks attractive at current levels
Kimbell Royalty Partners is well positioned to increase its dividend in 2024 with its recent acquisition of mi...
October 12, 2023, 6:27 pm
Pegasus resources gets key permit to move ahead with maiden drill program at pine channel uranium project
Pegasus Resources Inc. (TSX-V:PEGA) has received the Pine Channel mineral Exploration Permit for Diamon...
October 12, 2023, 5:44 pm